Tell Us What’s On Your Mind
The first two months of the ICER process are called the “Scoping” phase. During this time, the ICER team explores what is most important to patients and clinicians regarding the disease under review. Learning about your lived experience helps us determine what to include in our report*. For example, what types of health benefits are most important to you? What side effects are most problematic? We also want to hear about your experience with other existing treatments.
*We use the words review, report, and assessment interchangeably.
When Can I Share?
To help us with the scope of the review, we want to hear from you as soon as possible. You can submit your experiences through the Patient and Care Partner Questionnaire. In addition, we may reach out to discuss your experiences over a call. Check out a list of our current assessments here to learn about the timeline and the main point of contact.
Our Ongoing Assessments:
- Chemotherapy-Induced Neutropenia
- Diabetes: Type 2
- Hypertrophic Cardiomyopathy
- Myasthenia Gravis
Talk with us | Contact Yvette Venable, ICER’s Vice President of Patient Engagement at email@example.com
Share | your patient experience
Respond | to our work
Participate | in ICER’s public meeting
Empower | your community with evidence